Husky Injection Molding Systems is to acquire medical and closure mold maker, Schöttli Group, with the sale expected to close in December.
The deal means Schöttli customers will have access to Husky’s hot runner, controller and injection molding machines.
Following the closure of the transaction, Schöttli’s headquarters in Diessenhofen, Switzerland, as well as other facilities in San Dimas, California and Suzhou, China, will become part of Husky’s global network.
“We are excited about this new chapter in our company’s history and look forward to the benefits and synergies this acquisition will bring,” said Thomas Anderegg, president/CEO, Schöttli.
“Schöttli’s closures business complements Husky’s existing business by providing additional technology and capacity in both established and growing markets.”
Schöttli works in a number of medical applications, such as syringes, infusion/transfusion products, diagnostic systems and feminine care items.